
Celldex Therapeutics CLDX
€ 23.15
2.76%
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Celldex Therapeutics P/S 2011-2026 | CLDX
P/S Jährlich Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.187 | 0.338 | 0.85 | 0.286 | 0.0864 | 9.38 | 6.73 | 28.2 | 48.6 | 147 | 534 | 513 | 37.5 | 19.1 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 534 | 0.0864 | 96.1 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.99 | 1.02 % | $ 508 M | ||
|
Aclaris Therapeutics
ACRS
|
8.13 | $ 3.01 | 3.79 % | $ 233 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.08 | 0.65 % | $ 7.41 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 213.24 | 1.87 % | $ 5 B | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 11.86 | 2.24 % | $ 781 M | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Certara
CERT
|
5.15 | $ 8.81 | -0.56 % | $ 1.41 B | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 4.84 | 1.26 % | $ 116 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 95.2 | -0.08 % | $ 27.2 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 0.2 | 8.46 % | $ 435 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 26.78 | -0.81 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 9.61 | 0.63 % | $ 141 M | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
CorMedix
CRMD
|
2.09 K | $ 11.63 | -6.81 % | $ 592 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
CureVac N.V.
CVAC
|
281 | $ 4.52 | 0.89 % | $ 841 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
19.1 | $ 567.93 | -0.73 % | $ 43 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.6 | 1.96 % | $ 16.3 M | ||
|
Cytokinetics, Incorporated
CYTK
|
0.286 | $ 63.54 | 3.54 % | $ 7.12 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 91.93 | -0.63 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M |